Biotech startup Laekna snags $61m and 20 more deal updates worth $298m

Biotech startup Laekna snags $61m and 20 more deal updates worth $298m

18 May, 2022

biotech cancer CMG-SDIC Capital Laekna Therapeutics

Printed by Unregistered user on Sun, 27 Jul 2025 10:18:15 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

HK's Gusto Collective raises $11m and 21 more deal updates worth $233m

Venture Capital

China Deal Review: Startup funding value drops 42% to $2.7b in April

Read more from Greater China

Editor’s Take: The Week That Was—July 21-26

Hong Kong IPO boom triggers price war among banks